Richard Longnecker Selected Research

Richard Longnecker Research Topics

Disease

30	Infections 01/2021 - 02/2002
13	Neoplasms (Cancer) 10/2020 - 02/2002
9	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2022 - 11/2003
8	Lymphoma (Lymphomas) 01/2019 - 03/2009
5	Epstein-Barr Virus Infections 08/2014 - 12/2002
4	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 01/2015
4	Herpetic Keratitis 12/2020 - 10/2015
4	Latent Infection 12/2017 - 02/2002
3	Splenomegaly 01/2018 - 04/2011
3	Hodgkin Disease (Hodgkin's Disease) 05/2012 - 12/2003
3	Carcinogenesis 09/2007 - 02/2002
2	Herpes Simplex Encephalitis (Herpes Encephalitis) 01/2022 - 01/2021
2	Inflammation (Inflammations) 01/2021 - 01/2017
2	Keratitis 01/2019 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2018 - 04/2011
2	Vesicular Stomatitis 01/2013 - 02/2009
2	HIV Infections (HIV Infection) 12/2002 - 02/2002
1	Viral Encephalitis 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2017
1	Herpes Simplex 05/2017
1	Neuroblastoma 01/2017
1	Herpesviridae Infections (Herpesvirus Infection) 01/2017
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2016
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2012
1	Autoimmune Diseases (Autoimmune Disease) 05/2007
1	Nasopharyngeal Carcinoma 03/2006
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 05/2005
1	Carcinoma (Carcinomatosis) 02/2004
1	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2002

Drug/Important Bio-Agent (IBA)

18	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 02/2002
12	Glycoproteins (Glycoprotein)IBA 01/2019 - 02/2002
6	Member 14 Tumor Necrosis Factor ReceptorsIBA 12/2020 - 10/2011
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2005
4	Interferon Type IIBA 01/2022 - 01/2015
3	NectinsIBA 07/2012 - 10/2011
2	CholesterolIBA 11/2017 - 11/2003
2	Viral ProteinsIBA 01/2017 - 11/2004
2	Monoclonal AntibodiesIBA 05/2016 - 07/2003
2	Peptides (Polypeptides)IBA 07/2009 - 09/2007
1	InflammasomesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Chemotactic FactorsIBA 01/2021
1	CC ChemokinesIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	LigandsIBA 01/2021
1	E2F1 Transcription FactorIBA 10/2020
1	Cyclin D3IBA 10/2020
1	Interferon-betaIBA 01/2020
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2020
1	Ephrin-A2 (Ephrin A2)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	TAK-659IBA 01/2018
1	Syk KinaseIBA 01/2018
1	Lipoproteins (Lipoprotein)IBA 11/2017
1	Virus ReceptorsIBA 01/2017
1	Single-Chain AntibodiesIBA 01/2017
1	dinutuximabIBA 01/2017
1	VaccinesIBA 11/2016
1	ibrutinibIBA 05/2016
1	Agammaglobulinaemia Tyrosine KinaseIBA 05/2016
1	Phosphotransferases (Kinase)IBA 12/2015
1	Dasatinib (BMS 354825)FDA Link 07/2012
1	Sirolimus (Rapamycin)FDA Link 04/2011
1	Immunoglobulins (Immunoglobulin)IBA 03/2010
1	Tyrosine (L-Tyrosine)FDA Link 03/2009
1	Pharmaceutical PreparationsIBA 03/2006
1	Messenger RNA (mRNA)IBA 05/2005
1	AntigensIBA 05/2004
1	Serine (L-Serine)FDA Link 02/2004
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2004
1	methyl-beta-cyclodextrinIBA 11/2003
1	LipidsIBA 11/2003
1	Nystatin (Mycostatin)FDA LinkGeneric 11/2003
1	Viral AntigensIBA 09/2003
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 02/2002
1	Histocompatibility Antigens Class IIIBA 02/2002

Therapy/Procedure

6	Therapeutics 01/2021 - 02/2002
2	Organ Transplantation 12/2002 - 02/2002
1	Immunomodulation 01/2017
1	Transplantation 05/2016
1	Lenses 05/2012